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1. Introduction
In this chapter, there is insufficient space to exhaustively review the research which has
been carried out on internal radionuclide effects. I hope only to highlight evidence which
shows that internal radionuclides cannot be assessed by the current radiation risk model,
and to suggest some research directions that may enable a new model to be developed, one
which more accurately quantifies the real effects of such exposures. The biological effects of
exposure to ionizing radiation have been studied extensively in the last 70 years and yet
very little effort has gone into examining the health effects of exposure to internal incorpo‐
rated radionuclides. This is curious, since the biosphere has been increasingly contaminated
with novel man-made radioactive versions of naturally occurring elements which living
creatures have adapted to over evolutionary timescales, and intuition might suggest that
these substances could represent a significant hazard to health, one not easily or accurately
modelled by analogy with external photon radiation (X-rays and gamma rays).
The question of the health effects of internal radionuclide exposures began to be asked in the
early 1950s when there was widespread fallout contamination of food and milk from atmos‐
pheric nuclear tests. It quickly became the subject of disagreements between two committees
of the newly formed International Commission on Radiological Protection (ICRP)[1]. The
questions of the equivalence of internal and external radiation exposure, which were the ba‐
sis of these disagreements, have still not been resolved. In the West, up to very recently, the
whole spectrum of health effects from internal incorporated radionuclides has focused on
animal studies of Radium, Plutonium and Strontium-90 and human retrospective studies of
those individuals exposed to Radium-226 and Thorium-232 in the contrast medium “Thoro‐
trast”. These studies suffer from a number of problems which will be discussed.
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Soviet scientists were more interested in internal radiation effects from fission-product radi‐
onuclides, but unfortunately their valuable studies have been difficult to access since they
are published in Russian. In 1977 Gracheva and Korolev published a book summarising
work in this area which was translated in India in 1980 as Genetic Effects of the Decay of Radio‐
nuclides in Cells [2]. This presented a wealth of interesting data relating to beta emitter ge‐
netic effects in various systems and drew attention to the distinction that must be made
between external and internal radiation. This is important since the whole assessment of ra‐
diation in terms of health has been through the quantity “absorbed dose” and what can be
called the bag-of-water model.
In this bag of water model, illustrated in Fig 1, the total energy transferred by the radiation
to living tissue is diluted into a large mass, greater than a kilogram, as if the effects were
uniform throughout the tissue being considered. In Fig 1 the tissue mass A represents an ex‐
ternal irradiation by X-rays or gamma rays and here the effects are uniform across the tissue.
But in the case B, for internal irradiation, it is clear that it is possible, for certain kinds of
exposure, for tissue local to the source to receive very large amounts of radiation energy at
the same overall energy transfer to the tissue mass.
Figure 1. Comparing external and internal irradiation: the ICRP/ ICRU bag of water model. In case A, external radia‐
tion (X-rays or gamma rays) there are 20 events uniformly spaced throughout the tissue and the “absorbed dose” (see
text) at any microscopic point is evenly distributed. In case B, for internal irradiation (here from a radioactive particle)
there is a very large transfer of energy to a small tissue volume and the concept of “absorbed dose” does not apply.
Thus,  in  the  historic  and  also  the  current  system of  radiation  protection,  those  experts
who assess radiation risk, who are termed Health Physicists,  calculate the cumulative ab‐
sorbed dose in Grays, i.e. in terms of the total energy in Joules imparted by the beta elec‐
tron or alpha particle decays of the internal radionuclide contamination to one kilogram
of tissue. For this calculation, the tissue is modelled as water. For example, those whose
body contains 100 Bq of Strontium-90 are assessed, for the purposes of radiation protec‐
tion, as having received a cumulative absorbed dose of 100 x w where w is the “cumula‐
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tive (absorbed) dose coefficient”, obtained from measurements of the biological half life of
the Strontium in the body and the decay energy of each decay in Joules. This number w is
to be found in a Table published by the ICRP. In the case of the Strontium-90 contaminat‐
ed individual, if the person weighed 50 kg, then the mean activity concentration would be
2 Bq/kg. The resulting absorbed dose would then be 2 x 2.8 x 10-8 (this is the ICRP 72 dose
coefficient [3]).  In other words,  the committed dose is  5.6 x 10-8  Sv (0.056 μSv).  But can
this be safely compared with a dose from a chest X-ray (40 μSv ) or from natural back‐
ground radiation (2500 μSv) or from a high dose acute exposure to gamma rays from an
atomic bomb linearly scaled to zero dose (the current way of modelling radiation effects)?
This chapter explores this question. It is one which has become increasingly necessary as
serious  health  effects,  including  cancer  and  leukemia,  have  been  reported  in  those  ex‐
posed to internal radioactivity in areas contaminated by radionuclides released from nu‐
clear sites, weapons testing fallout and accidents like Chernobyl and Fukushima, at very
low conventionally calculated “absorbed doses”.
The matter  has  been discussed in  some detail  since  1998 by the  independent  European
Committee on Radiation Risk (ECRR) whose reports [4, 5] provide a methodology for as‐
sessing health effects through a system of weighting factors based on available data.  As
more  and more  evidence  emerged after  1995  that  something  was  very  wrong with  the
ICRP absorbed dose approach to internal radiation, the UK government set up a Commit‐
tee Examining Radiation Risk from Internal Emitters (CERRIE). Since there were (and are)
political  dimensions to the issue,  the committee was composed of  scientists  and experts
from the  nuclear  industry  and the  official  radiation protection organisations  in  the  UK.
Unfortunately the 4-years process ended in acrimony, legal threats to member of the com‐
mittee, and failure to agree a final report. Two reports were issued [6, 7]. However, there
was agreement that there were reasonable concerns about the safety of employing “absor‐
bed dose” for certain internal radionuclide situations, and similar concerns about the safe‐
ty of  the ICRP model were made in 2005 by the French IRSN [8].  The error factor that
these discussions led to was believed by different ends of the CERRIE process to be be‐
tween 10-fold and 1000-fold. More recently, the value put on this error factor by the re‐
tired Scientific Secretary of the ICRP at a meeting in Stockholm in 2009 was “two orders
of  magnitude”.  What this  means,  in our Strontium-90 case above,  is  that  the dose from
100Bq contamination to the whole body is no longer 0.056μSv but may now be between
0.56μSv and 56μSv and the risk of fatal cancer is proportionately increased. To put this in
perspective, the mean Sr-90 dose over the period 1959-1963 to individuals in the northern
hemisphere was given as about 1 mSv [9]. The ICRP risk model gives a 0.45% per Sievert
excess  lifetime  cancer  risk.  Epidemiological  studies  suggest  that  the  cancer  “epidemic”
which began in the 1980s in areas of high rainfall and fallout is a consequence of the earli‐
er fallout exposures [10]. The weighting of dose necessary to explain this is greater than
300 if calculated from the ICRP absolute risk factor of 0.05/Sv [5, 11]. Many other instan‐
ces  of  anomalous  health  effects  from exposure  to  internal  radionuclides  require  hazard
weighting factors of between 100-fold and more than 1000-fold, and these are consequen‐
ces of mechanisms which will be presented.
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2. Fundamental principles
Ionising radiation, however it is delivered, creates harmful effects by causing mutations in genetic
material both at the somatic level (cellular DNA) and germ cell level (heritable mutations).
The mutations are caused by alterations in the cellular DNA in the nucleus and in mitochon‐
dria. These are brought about by three mechanisms:
a. Direct ionisation of the DNA and subsequent chemical alteration of the bases to mole‐
cules which are not recognised as a coding signal.
b. Indirect ionisation of the DNA by reactive species produced by ionisation of water
(called Reactive Oxygen Species ROS).
c. A mechanism termed “Genomic Instability” which is an inducible cell-cell signal conse‐
quence of the production of ROS in the cytoplasm (non-DNA region) of an irradiated
cell. This process is communicable between cells in some way and even between indi‐
viduals and has been termed the “bystander effect”.
These mechanisms are well described in the literature and in textbooks, and the processes
described here can be found in the reports of radiation protection agencies e.g. [12].
Ionising radiation always transfers its energy to matter in the form of structured tracks of charged
particles. Photon radiation (gamma and X-radiation) is absorbed by matter mainly through
Compton Effect, Photoelectron, and Pair-production. All these cause the creation of tracks of
energetic electrons which carry the energy of the original photon and collide with molecules
in the absorbing medium causing ionisation. The ionised fragments (in the case of living tis‐
sue mainly of water) then recombine or react with local molecular entities causing chemical
changes in the molecular structure. Various chemical reactions take place e.g.
H2O (radiation)→H2O++ e-
H2O+ + H2O→OH* + H3O+
The free radical OH* has an unpaired electron and is highly reactive; it will combine with
local species including DNA if that is close to the track. If it reacts again with water species
the result is a range of highly reactive fragments which are collectively described as Reactive
Oxygen Species. The process can be written:
H2O (radiation)→eaq, H*, H2O2, H2, OH*.
The relative concentrations of the main ROS are [12]:
eaq (hydrated electron) 45%
OH* (hydroxyl radical) 45%
H* (hydrogen radical) 10%
These reactive species attack molecules in the cell and cause damage; because it is an oxidis‐
ing agent the OH* radical is likely to be the most effective DNA damaging agent, abstracting
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a hydrogen atom from the deoxyribose moiety of DNA yielding a highly reactive DNA radi‐
cal. This will then rearrange or react with local molecules to produce a new molecule in the
DNA coding sequence, the gene, a molecule which is unrecognizable to the coding transfer
process and alters the message of the gene.
It seems that evolution has recognised the dangers of high levels of cellular ROS and has
developed a process to deal with the threat to the species or to the organism. At the organ‐
ism level the process involves firstly the existence of double strands of DNA which permit
repair of ionisation damage to a base located on one strand by copying from the opposite
strand. This type of lesion, termed a “point mutation” is a more likely result for chemical
mutagenesis or random attack by ROS species present in the cell at some background con‐
centration (as a by product of other chemical processes in the cell). In some cells, the result
of DNA damage is programmed cell suicide, termed apoptosis. But at the organism level,
one response is the induction of genomic instability, whereby a signal is switched on in the
DNA resulting in increased levels of random mutagenesis built into cell replication of the
damaged cell and also bystander cells. The exact purpose of this process, which is well
documented, is uncertain [13]. If the damage is more extensive, involving locally multiply
damaged sites (LMDS) or both strands, it becomes more difficult to accurately repair the
material and either a fixed mutation or cell death results.
Internal exposure results from the radioactive decay of radionuclides incorporated into tissue
through inhalation or ingestion. There are three principle types of decay which represent the
majority of all internal exposures. Gamma decay, which produces fast electron tracks, β de‐
cay which also produces fast electron tracks, and alpha decay. In addition there are also
short range electron tracks from Auger decays. The main internal nuclides of environmental
and radiobiological importance are listed in Table 1.
Apart from effects at the nuclide (recoil, transmutation) β decay is indistinguishable from
the fast (photoelectron) electron tracks produced from gamma and X-ray interactions. With
β-decay, unstable elements change into elements with one greater atomic number Z and
emit an electron in the process; they may also emit a gamma ray. Sometimes the daughter
nuclide is also unstable and may further decay. An example is Strontium-90 which emits a
β-particle of endpoint energy 546 keV (kiloelectron volts) and transmutes into Yttrium-90
which further emits a β−particle of endpoint energy 2280 keV and transmutes into stable
Zirconium-90. There are several series decay sequences in which ten or more unstable nu‐
clides are formed, one from another. An example is the natural α-emitter Uranium-238
which decays through twelve sequential unstable radionuclides until the sequence stops at
stable Lead-206. Transmutation involving α-decay involves the change of the chemical ele‐
ment to one with Atomic Number Z four places lower on the Periodic Table. Thus U-238
emits an α-particle and decays to Thorium-234.
There is strong evidence that damage to DNA is the cause of the effects of ionising radiation. For
example, experiments have been carried out with nuclides which have short range electron
emissions (Auger emissions) or Tritium chemically incorporated into DNA precursors so
that these elements become covalently bonded to the DNA. The measured harmful effects
are up to 100-times greater than would be predicted from the “absorbed dose” showing that
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it is the ionisation in the DNA that is key to the destruction of the cell [14, 15]. Another argu‐
ment is based on the effects of the weak β-emitter Tritium, as tritiated water HTO. The
measured effects of Tritium exposure are not too different from that expected on the basis of
the absorbed dose (although it may be higher, see below). But clearly the Tritium will be
evenly distributed throughout the cell. Since the beta energy of Tritium is only 6 keV the
electron track range will be less than 0.5 μ and the ionisations will occur in clusters, uni‐
formly distributed in the cell but with no overlap. It is clear that only those clusters which
are close to the DNA will have an effect on the DNA, and the great majority of the energy
will be “wasted” in the cytoplasm. Thus for a Tritium dose modelled by ICRP as 1 mSv, only
a very small fraction of the Tritium decays will contribute to the effect.
The main target DNA, in the cell nucleus, represents a very small fraction of the total materi‐
al in the cell. In a 10 μ diameter cell (mass 520 pg) there is 6 pg of DNA made up of 2.4 pg
bases, 2.3 pg deoxyribose, 1.2 pg phosphate. In addition, associated with this macromolecule
are 3.1 pg of bound water and 4.2 pg of inner hydration water [16]. Since absorbed dose is
given as Joules per kilogram, if it were possible to accurately target the DNA complex alone,
a dose to the cell (mass 520 pg) of 1 milliJoule per kilogram (one milliGray, one milliSievert)
would, if absorbed only by the DNA complex (6 pg), represent a dose of 520/6 = 87 mSv to
the DNA. It is possible to imagine the DNA as an organ of the body, like the thyroid gland
or the breast. If this is done, then there should be a weighting factor for its radiobiological
sensitivity of 87 which would be based on spatial distribution of dose alone. Of course, for
external photon irradiation, to a first approximation, tracks are generated at random in tis‐
sue. Therefore only a small proportion of these tracks will intercept the DNA but the inter‐
ception will be mainly uniform, and the health effects from such external exposure may be
assumed to be described by the averaging approach of “absorbed dose”. This is not the case
for internal exposures from radionuclide decays in a number of quite specific circumstances
which will be described below (see [5]).
The calculations of “absorbed dose” also assume that the medium irradiated has uniform isotropic
qualities with an absorption coefficient roughly equivalent to that of water. However the ab‐
sorption of gamma radiation is proportional to the 4th power of the atomic number Z. It fol‐
lows that the probability of absorption of gamma radiation will be location specific, and this
is highly relevant to a number of high Z elements, either biologically necessary (Iodine,
Z=53) or as contaminants (Uranium Z=92) [17].
Radionuclides are primarily chemical elements with the affinities and reactivities of the non-radio‐
active forms of these elements. They will therefore have quite specific biochemical pathways
in the body and may accumulate at positions in cells as a result of their chemical group, va‐
lency, ionic volumes, charge etc. This will result in high local doses at sites where they accu‐
mulate. In addition, the decay of a nuclide attached to some cell structure or macromolecule
will result in the alteration of the radionuclide into a different element with a different
charge, with resultant recoil energy. This will always break the chemical bond and result in
ionisation. Thus there will be local ionisation and this may be on some critical macromole‐
cule like DNA. These localisation and transmutation effects were studied in the 1960s but no
attempt has been made to incorporate them for radiation protection purposes.
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The decay of a radionuclide attached chemically to the DNA is illustrated schematically
in Fig 2.
Figure 2. Certain radionuclides (Sr-90, Uranium) bind to DNA and when they decay cause (a) transmutation ionisation
and (b) local electron emission ionisation (Auger, β particle) on or close to the critical target for radiation effects.
Cells have two phases of activity during their lifespan. They are mostly in a quiescent phase where
DNA is not localised spatially. For a short period at the end of their lifespan, when they rep‐
licate, they are in a cell cycle phase. In this phase they are much more sensitive to irradia‐
tion. Therefore this repair replication phase represents a critical window for mutagenesis if
it can be engineered. The radiation sensitivity of the repair replication phase has been stud‐
ied extensively and it was suggested [18, 19] that two irradiation events separated by about
10-12 hours could represent an enhanced hazard since the first pushed quiescent cells into
repair replication and the second damaged them during the sensitive 12 hour period. The
idea is termed the Second Event theory. There is some evidence for it from work with split
doses of X-rays. It will be discussed below.
3. Concerns about internal radionuclides
To summarise, the position is that the current assessment of harm from radiation exposure is based
on a quantity which does not assume any structure in the tissue being irradiated. It does not
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distinguish between different radionuclides on the basis of their chemical properties except
at the organ level (Iodine/ thyroid) and it does not include any weighting for chemical affini‐
ties for DNA, nor for transmutation effects. It does not consider the fractionation of doses
within cell cycle repair times. Risk factors are based almost entirely on acute external gam‐
ma ray exposures. The main concerns are for radionuclides which are significant environ‐
mental contaminants and which are listed in Table 3.
3.1. Proximity effects on local doses
Since the genotoxic effects of radiation are mediated by ionisation and the local concen‐
tration  of  reactive  oxygen  species,  it  is  firstly  this  local  ionization  density  that  is  the
proper measure of  the effectiveness of  a  radiation exposure.  The current  risk model  ac‐
knowledges this by weighting the highly ionizing α particle tracks by an arbitrary factor
of 20. But of concern is the overlap of such tracks, and of electron tracks from β−decays
or  Auger  electron  showers  with  active  DNA in  the  nucleus,  and especially  at  the  time
when this is in some critical state, as in cell repair/division. For externally delivered pho‐
ton radiation, it can be assumed (in the absence of high-Z photoelectron effects) that ion‐
ization  is  uniform  across  tissue.  Under  these  circumstances  it  is  only  a  matter  of
probability  whether  a  cell  is  intercepted  by  a  track  or  not.  It  has  been  calculated  [20]
that,  at  normal  Natural  Background  levels,  each  cell  in  the  body  will,  on  the  basis  of
probability,  receive one hit  per year (a hit  being the traversal  of  the cell  by an electron
track). Of these hits, some small proportion will involve a track that intercepts the DNA
and may cause damage.  This damage,  if  it  results  in a point mutation,  will  be repaired
before cell division. The ionisation density in a photoelectron track is assumed to be low.
Therefore, for external exposure, a dose of 1 mSv to the whole body can be assumed to
provide a dose of 1 mSv to the cell  on average. At the cell  level,  this is not the case. A
cell can be intercepted by a track or not. If not, then the cell dose is zero and there is no
ionisation.  If  so,  then  the  cell  dose  can  be  greater  than  1  mSv.  The  dose  to  the  DNA
from such processes will again be either zero or some dose greater than 1 mSv.
For internal exposures, the probability of interception of the track is clearly a function of the
distance of the nuclide from the DNA. In addition, internal exposures may be to α tracks
which carry significantly more ionisation density. The range of most α tracks (which carry
about of 5 MeV energy) is about 4 cell diameters and so, theoretically, the track dose to the
cell from one decay is in the region of 500 mSv. The matter becomes serious when the nu‐
clide is an alpha emitter but also has a high chemical affinity for DNA. This is the case for
Uranium. Anomalous effects from internal nuclides have been known for a long time. Early
studies of cell doses from Tritium were carried out by Apelgot [21] and Robertson and
Hughes [22] and reviews of Tritium and of S-35 and P-32 studies are found in ref [2]. In or‐
der to emphasise the profound effects which can be identified in internal exposures, the case
of Carbon-14 will be examined in greater detail below.
The cell dose from any decay is fairly simple to approximate on the basis of a continuous
slowing down approximation and the assumption that the energy delivered along a track is
a constant function of the track length. Electron track lengths in tissue for a range of energies
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are given in Table 1. These apply also to photoelectrons which have energies almost equal to
the gamma photons that produced them. Assuming a cell diameter of 10 μ, the energy de‐
posited in the cell is merely the decay energy divided by the track length in the cell. This is
then converted into Joules (1 keV = 1.6 x 10-19 J) and divided by the mass of the cell in kg. For
a 10 μ diameter cell this is 5.2 x 10-13 kg. For the Strontium-90 example, a single decay track
will deposit approximately 1 mSv in each cell traversed by the track.
Energy (keV) Range (cms)
*Linear energy
transfer
keV/μ
Examples (maximum β−energy, keV)
5 1.2 E-4 4 Tritium (5.7)
15 5.2 E-4 2.9
20 8.6 E-4 2.3
150 2.8 E-2 0.53 Sulfur-35 (167);Carbon-14 (155)
500 1.78 E-1 0.28 Strontium-90 (546) Caesium-137 (514) Iodine-131 (607) Caesium-134(658) Barium-140 (168)
1000 4.42 E-1 0.22 Iodine-132 (1610,1210,1040) Barium-140 (1020,1010)
2000 9.92 E-1 0.201 Yttrium-90 (2280) Iodine-132 (2160)
* this is simply the loss of energy of the particle over unit distance
Table 1. Continuous slowing down range in muscle tissue for electrons in g cm-2 (values very similar to range in water)
(from ICRU Report 35 Table 2.5 [23])
3.2. Calculating the spatial effect enhancement
The spatial effect enhancement is the probability of an ionisation track from an internal nu‐
clide intercepting the DNA at some given level of ionisation density, compared with the
probability of this happening from external radiation.
Thus we take the mutagenic event of interest to be associated with absorbed dose (energy
per unit mass) in a volume element of a track which is coincident with active DNA in space
and time. For nuclides with chemical affinity for DNA this ratio is clearly very large. In the
limiting case of covalent binding it can be assumed that approximately half of the decays of
the bound nuclide traverse the DNA, and in addition the transmutation of the nuclide causes
a point ionisation at its position. In the limit this probability will be 1; for example, C-14
which is incorporated into one of the DNA bases will decay and change into Nitrogen. This
will immediately destroy the purine or pyrimidine base which it is part of and will intro‐
duce a mutation which may or may not be repaired.
The probability of the interception of a charged particle track intercepting the DNA depends
on the distance of the point source and the dimensions of the DNA target employed. The
cross sectional diameter of one strand is about 0.3 nm but, in mitosis, various much larger
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condensed targets exist. The principle is the same, however: the probability of intercepting
the target falls off rapidly with distance. The result for a condensed DNA target of cross sec‐
tion 0.1 x 1 μ is given in Fig 3. The calculation is given in Appendix A. The result confirms
what is intuitively obvious: the effect of radionuclide decay in the cytoplasm is much less
harmful than for nuclides bound to DNA. This is particularly significant for the α-emitters
which have chemical affinity for DNA, Uranium (as UO2++) and, possibly, Plutonium.
Figure 3. Approximate probability of a track interception of a DNA target modelled as a strip of 0.1 x 1 μ by distance
in μ from target. In this model, the maximum probability is 0.5 for a nuclide located on the surface of a flat strip.
One other simple way to illustrate this spatial effect is merely to consider the tissue as two
compartments, an organ A which may be called “DNA” and one B which may be called “ev‐
erything else”. The current ICRP risk model calculates the absorbed dose of any internal ex‐
posure by dividing the total decay energy by the mass. This would not distinguish between
compartments A and B; both would receive the same dose. But as far as cancer is concerned
(or other consequences of genetic damage) all the ionisation in compartment B is wasted. It
has no effect. Therefore it is the dose to compartment A that is the cause of the effect. This
would suggest that the spatial enhancement is at minimum the ratio MassB/MassA or about
90-fold. This assumes that all the DNA in the cell is a critical target which is unlikely to be
the case. If the critical DNA represented even 1/10th of the total cellular DNA, the spatial en‐
hancement from track interception alone would be 900-fold.
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3.3. Double strand breaks
At natural background radiation levels, where there is one “hit” per cell per year, the Poisson
probability of multiple tracks across the DNA strand is low. Most of the “hits” are repairable
and the biological response is proportional to the dose. But it is believed on the basis of good
evidence that genetic mutations result from multiply damaged sites [12]. If two adjacent DNA
strands are broken, then repair is not possible since there is no template from which to copy the
correct sequence. Ward et al. (1988) [16] compare DNA damage necessary to inactivate ex‐
posed cells between radiation and chemical mutagens. Table 2 lists some of the results:
Agent DNA lesion No of lesions per cell
Ionizing radiation SSB 1000
DSB 40
Total LMDS 440
Benzo[a]pyrene 4,5 oxide Carcinogenic adduct 100,000
methylnitrosourea 7-methylguanine 800,000
Aflatoxin Carcinogenic adduct 10,000
Table 2. Yields of DNA damage necessary to kill 63% of exposed cells [16]
From Table 2 it  is clear that ionizing radiation is more effective than the most powerful
chemical  carcinogens in causing genetic  lesions to the DNA, but it  is  the double strand
breaks  (DSBs)  and  LMDS  which  are  the  most  efficient  processes.  From  simple  kinetic
theory it is clear that the probability of inducing double strand breaks or LMDS will in‐
crease as the number of tracks per unit time increases. At low background external doses
this is very unlikely. But as the dose rate increases, so the likelihood of multiple tracks in‐
creases (for a discussion see [18]). This is not true for a number of internal exposure situa‐
tions where multiple tracks can occur at very low doses, conventionally assessed. The first
is exposure to particulates.
Radioactivity from releases from nuclear explosions, e.g. accidents like Chernobyl, or from
weapons tests or Uranium weapons is partly in the form of sub-micron particulates which
are respirable and can be translocated from the lung. Tissue near such particles will receive
multiple tracks even though the dose, as assessed as energy per unit mass may be very low.
Similar multiple track effects can occur close to high Z element particles whether they are
intrinsically radioactive or not, e.g. platinum (catalysers), bismuth, gold (prostheses), due to
secondary photoelectron conversion from natural background gamma radiation [7, 17]. The
second is where a relatively immobilised nuclide has a sequential decay pathway and so
there is more than one decay from approximately the same position. This situation is more
genotoxic when the decays occur within the repair replication cycle; the Second Event [7]
and this situation will be discussed separately.
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Radionuclide
Half life
(Decay
product)
Decay Reasons for concern Other remarks
Tritium H3 12.32 yHelium-3
Low energy
β
Ubiquitous; Discharged in large
amounts by all nuclear sites and
weapons tests; present as tritiated
water and easily incorporated into
body. Can be present as organically
bound tritium which may accumulate
in the body.
Evidence of serious genetic
effects in invertebrate
development at very low doses;
short range of β decay causes
high ionisation density.
Carbon-14 5730 yNitrogen β emitter
Discharged by nuclear sites,
particularly reprocessing sites
(Sellafield) and weapons tests.
Incorporated into the carbon of the
body
Doses by ingestion mainly of
vegetables, milk, fish. Both
Carbon and hydrogen (Tritium)
make up the structure of living
systems. Transmutes to a gas,
nitrogen.
Sulphur-35 87 daysChlorine β emitter
Discharged from nuclear sites.
Concentrates in foods.
Sulphur also a part of internal
macromolecules in living
systems. Transmutes to a
reactive gas, Chlorine
Strontium-90 28.9 yYttrium-90 β emitter
Globally Widespread. Atmospheric
test fallout, nuclear sites, accidents
(Chernobyl, Fukushima); Group 2
affinity for DNA
Second event nuclide with
daughter Y-90 of concern since
it binds to DNA
Krypton-85
10.7 y
Rubidium-8
5
β emitter
Very large amount routinely released
from nuclear sites is building up in
atmosphere.
Very soluble in fats and
therefore can build up in body
fat (beast tissue, lymphatic
tissue) following inhalation
Barium-140
12 d
Lanthanum
-140
β emitter
Large quantities from nuclear
weapons tests; Group 2 affinity for
DNA
Second event emitter binds to
DNA. Of concern in assessing
effects of nuclear atmospheric
tests and accidents
Iodine-131
8 days
Xenon-131
m
βγ emitter
Large amounts from accidents,
licensed releases. Affinity for Thyroid
and Thyroxine in circulating blood
Second event emitter with
daughter Xe-131m short half
life. Transmutes to a gas.
Tellurium-132 3.25 dIodine-132 βγ emitter
Released in large amounts from
accidents; daughter is Iodine 132 Second event series
Caesium-134 2 yBarium-134 βγ emitter
Released from nuclear explosions,
accidents Binds to muscle
Caesium-137
30 y
Barium-137
m
βγ emitter Released from nuclear explosions,accidents, nuclear sites under licence
Binds to muscle; concerns over
effects on heart in Chernobyl
contaminated areas.
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Radionuclide
Half life
(Decay
product)
Decay Reasons for concern Other remarks
Radium-226 1599 yRadon-222 α emitter
NORM Contamination near oil and
gas processing sites; widely studied
but problems with the studies (see
text). Decays to Radon gas.
Group 2 Calcium seeker. Binds
to DNA. Evidence of non-cancer
reduction in lifespan in human
studies.
Polonium-210 139dLead-204 α emitter
Releases from nuclear sites; daughter
of Lead 201 which can build up in
environment as a result of
contamination from NORM
Uranium-238 4.5 x 10
9y
Series α emitter
Releases from nuclear sites;
contamination from mining and
processing; from weapons fallout
and accidents; from battlefield
weapons usage and testing.
Widespread in the environment but
generally not measured near nuclear
sites
High Z photoelectron effects;
binds to DNA; considerable
evidence for its anomalous
genotoxicity
Plutonium-239
2.4 x 104 y
Uranium-23
5
α emitter
Releases from nuclear sites, weapons
test fallout, widespread
environmental contaminant
Binds to DNA (?) evidence for
anomalous genotoxicity
Table 3. Internal radionuclides of concern
Third, if an alpha emitting nuclide is either randomly positioned near or chemically attract‐
ed to the DNA, there is a significant probability that the highly ionising track will traverse
the two strands of the DNA and damage multiple sites. This is the origin of the high efficien‐
cy of alpha emitters which resulted in their being weighted by ICRP. Fourth, there are situa‐
tions where dose is delivered by very low energy beta emitters; the best example is Tritium.
Because dose is assessed as energy per unit mass, the very low decay energy of Tritium
means that there is a large number of decays from different atoms of Tritium (90 tracks) to
deliver the same dose as one 500 keV β decay from Caesium-137 or from the traversal of a
cell by a 500 keV photoelectron track. This would suggest a mechanism backing the evi‐
dence (see below) that Tritium represents a greater mutagenic hazard than is calculated on
the basis of its absorbed dose.
3.4. Summary of enhancement mechanisms; caveats over high dose studies
The target for radiation effects is the DNA, the nuclear DNA and the sensitivity to radiation
varies depending on whether the cell is in quiescent phase or in repair replication. Within
the 12 hour repair replication period there are other sensitive windows. The end point for
radiation damage to the DNA can be genetic mutation leading to heritable damage (in germ
cells) or cancer, but if the ionisation density is too great, or the sequential hits to close to‐
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gether then the cell will die. The interesting thing then is that this will decrease the fixed muta‐
tion rate and therefore will decrease the cancer rate. Thus we would not expect studies of high
dose and high dose rate to elicit information which informs on low dose and low dose rate.
The dose/ dose rate response in cancer studies will inevitably have a complex character for
this reason. This is clear from the results of retrospective studies of Radium and Thorotrast
contamination, studies which have been influential in supporting the current radiation risk
model, an issue with will be discussed further below. The key point is that, for certain inter‐
nal exposure regimes, the ionisation density at the DNA and the damage to the DNA can be
extremely high even though the absorbed dose, as calculated by the current methodology,
may be extremely low.
The regions of internal and external dose, are illustrated in Fig 4.
Figure 4. Regions of interest in a theoretically predicted dose response relation (see text and ECRR2010). Exactly this
dose response is seen in infant leukemia rates after Chernobyl in Greece, Germany (3 dose regions) Wales, Scotland
and Belarus (see [25]).
The analysis from ECRR 2010 [5] is described in Fig 4, the end point is assumed to be cancer
rate. Q is the background rate. There are three regions. In the first region A, sensitive cells in
repair replication are first mutated (positive slope) and then overwhelmed (negative slope).
Next, in region B the cells in quiescent phase are mutated and eventually overwhelmed in C.
This is also the organism response since at high doses C the organism suffers from non can‐
cer causes of death which affect the cancer rates, reducing them as the dose increases. These
responses are seen in many epidemiological and animal studies but are generally misinter‐
preted. Burlakova has made a special study of dose response relationships and has shown
the type AB response for a wide range of objective markers of DNA damage and also whole
organism end-points [24].The dose response is seen in, and most easily explained in, infant
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leukemia after internal radiation exposures. As the exposure increases, foetal death ensues
at some point, and the leukemia rate in the infant falls [25]. If the dose response is assumed
to be linear, and the low dose data points assumed to be data scatter, a line drawn between
the background cancer rate Q and the peak in region B cuts the response line in such a way
as to suggest that radiation is actually reducing cancer rate, the so-called hormesis theory.
The analysis in ECRR2010 points out that this is a misinterpretation of the data.
From what has been discussed, it is possible to summarise the mechanisms that may lead to
increased risk of damage to DNA, and indeed to decreased risk in the case of high local
doses which will kill rather than fix mutations. The mechanisms are listed in Table 4 where
enhancements from alpha emitters with affinity for DNA may deliver such high local doses
as to inactivate the cell.
Mechanism Range Examples
Spatial location
DNA affinity 0.1-100 Uranium, Strontium, Barium, Radium Plutonium?
Membrane affinity ? Caesium, Potassium, Rubidium, Chlorine, Sodium
DNA incorporation Very high Tritium, Carbon-14
Particulates 10-1000 Uranium. Plutonium
Protein incorporation ? Sulphur-35, Tritium, Carbon-14
Transmutation 5-100 All covalently bound internal nuclides e.g. Sulphur-35,Tritium, Carbon-14
Temporal location
Critical cell lifespan phase interception
by immobilised source 0.01-100
Strontium-90 , Tellurium-132, Tritium, Radium-226,
particulates
Critical repair replication window
interception 0.01-1000
Strontium-90 , Tellurium-132, Tritium, Radium-226,
particulates
Fat soluble noble gases ? e.g. Kr-85
High Atomic Number photoelectron
amplification
U-238
100-1000
Uranium, Platinum, Gold, Bismuth, potentially all
elements with Z"/>53
Table 4. Main mechanisms of enhancement of genetic hazard from internal irradiation (see ECRR2010).
4. Specific concerns and new research directions
4.1. Location enhancement and chemical affinity
Concern has  been shown since  the  1950s  that  radionuclides  of  Group 2  in  the  Periodic
Table, notably Strontium-90 and Barium-140, may have high affinity for DNA. These ele‐
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ments  exist  in  solution  as  dipositive  ions  which  are  known  to  concentrate  in  organs
(bones,  teeth)  which  have  high  phosphate  concentrations.  Calcium and Magnesium are
also known to bind electrostatically to the DNA Phosphate backbone and to stabilise its
conformation. It is therefore likely that Strontium, Barium and Radium also have such af‐
finity. The concentration of the radiation risk establishment on Radium epidemiology has
been  based  on  an  end-point  of  bone  cancer  because  the  nuclide  concentrates  in  bone.
The affinity for DNA has been overlooked.
In the 1960s, for the reason that it was believed that Strontium would bind to DNA, and be‐
cause some experiments showed that this was the case, there was significant concern about
Strontium-90 contamination of milk. Mouse experiments demonstrated effects on intrauter‐
ine foetal death [26], and studies on rats showed development effects from Sr-90 [27]. There
were effects at very low doses from Sr-90 [28], and by 1970 the director of the UK Medical
Research Council suggested that further interest be taken in research on Sr-90 [29]. However
nothing was done. In 2004, the CERRIE committee unanimously called for there to be fur‐
ther research into the effects of exposure to Sr-90 [6]. Also classified with these Group 2 is
Uranium which exists in solution as the dipositive ion UO2++ the Uranyl ion. This has very
high affinity for DNAP [30] which led to its introduction as a chromosome stain for electron
microscopy as early as 1960 [31].
The most necessary research is to measure the affinity of Strontium, Radium and Uranyl ion
for chromosomes in vivo. Owing to the high opacity of Uranium there are certainly potential
electron microscope methods for examining its location in cells in vivo. It might be possible
to employ autoradiography to measure the affinity constants in vivo for Ra-226, Sr-90 and
Ba-140. Affinity constants for DNAP can be easily measured in vitro for Strontium, Barium
and Radium but this does not appear to have been done.
Animal studies of Radium and Uranium have assumed that the end point must be bone can‐
cer or leukemia, and that only high doses will cause cancer. Effects at low doses have been
assumed to be random scatter. It is suggested that low dose animal studies be undertaken
with lifespan observation of all possible conditions to resolve this issue.
1. There is the question of membrane affinity. If certain ions congregate at certain membranes,
the local ionisation density from radioactive decay will be higher than if these were uni‐
formly distributed in cytoplasm. Experiments with the nuclide Sodium-22 by Petkau
showed a supralinear dose response and effects at very low doses as calculated by us‐
ing the total solution volume as a denominator [32]. If such effects occur in vivo there
are a number of critical membranes which might be destroyed from internal radionu‐
clide ions. Experiments in vitro might involve K-40, and Cs-137.
2. DNA is made from Carbon, Oxygen, Hydrogen and Nitrogen. Carbon-14 and  Tritium can
both therefore become covalently bonded into the molecule,  and Tritium can easily
exchange with labile hydrogen atoms on -SH, -OH and –NH moieties. The resultant
decay  will  result  in  the  total  internal  rearrangement  or  local  reaction  resulting  in
permanent alteration of the molecule. This will produce a point mutation with 100%
efficiency. The electrons from the decay or reactive species created during the trans‐
New Research Directions in DNA Repair612
mutations through abstraction of protons from water may damage other local DNA
leading to LMDS or DSBs. In the case of C-14, the transmutation to N-14 will totally
destroy  the  molecule  since  the  two elements  have  different  valency,  outer  electron
structure,  and reactivity.  Owing to the long half-life of C-14,  experiments on its  ge‐
netic  effects  have been difficult  to  carry  out.  Nevertheless,  some studies  have been
published which show that these transmutation effects dominate the hazards of C-14
and Tritium incorporation (see below).
4.2. Particulates
The problem of the anisotropy of dose from internal “hot particles” was raised by Tamplin
in the 1980s [33]. It was discussed by CERRIE and was the subject of a review by Charles et
al in 2003 [34]. Since the 1950s, there has been a new class of internal radionuclide exposure
which has not existed throughout evolution. This is the sub-micron or nanometre diameter
radioactive particle. Particles below 1μ diameter can be inhaled and translocated from the
lung to the lymphatic system. They are created in nuclear explosions, from power station ac‐
cidents, from nuclear site releases and from Uranium weapons on battlefields. Depending
on their nuclide composition they can produce very high local doses to tissue in which they
become immobilised, but may also, depending on their diameter and composition, produce
lower doses. Two concerns are Uranium and Plutonium oxide particles. Both contaminated
large areas of land in Europe after Chernobyl. Both are resuspended from coastal sediments
where contamination exists e.g. the Baltic Sea and the Irish Sea and plutonium from this lat‐
ter source has been measured in coastal autopsy specimens [35], sheep faeces, and childrens
teeth [36]. The well known Seascale child leukemia cluster [37] was discussed by the author‐
ities [40] who dismissed the idea that the leukemia was caused by inhalation of plutonium
and uranium on the basis that the doses to the lymphatic system were below natural back‐
ground [38, 39]. However, the methodology employed diluted the particulate energy into a
lymphatic system modelled as several kilograms of tissue [38] rather than the tracheobron‐
chial lymph nodes which weigh about then grams and which are known to be the origin of
leukemia in some animals.
The  problem  with  the  hot  particle  issue  is  that  there  will  be  a  range  of  local  energies
(local dose) which will  have either little effect (A),  a genetic effect (B) or a killing effect
(C).  This  was  pointed  out  in  1986  following  Chernobyl  [41]  and  the  idea  is  illustrated
in Fig 5.  Regions A to C will  have dimensions resulting (a)  from the activity and com‐
position of  the particle  and (b)  from its  diameter.  A particularly interesting case is  that
of  a  weakly  radioactive  particle  like  U-238  produced  from  battlefield  use  of  Uranium
weapons,  so  called  depleted  Uranium.  Such  a  particle  may  be  more  carcinogenic  than
the much more radioactive plutonium particles found in the Irish Sea and epidemiology
seems  to  bear  this  out.  Of  interest  also  is  the  photoelectron  amplification  of  natural
background  radiation  by  internal  high  atomic  number  particles  like  Uranium-238,  but
also other elements (see below).  It  is  not sufficient to dispute the hazards from particu‐
lates  by  pointing  out  that  they  will  have  such  high  activities  that  cells  will  be  killed
rather than mutated e.g. [34, 6].
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Figure 5. Effects in cells local to “hot particles” (see text).
4.3. Protein and DNA incorporation and transmutation
The inactivation of key enzymes or DNA by incorporation through biosynthesis of radionu‐
clide substituted precursors is a matter that seems to have been entirely overlooked in radio‐
protection. The environmental contamination nuclides which will inactivate biological
molecules are those from which they are constituted, namely Carbon (C-14), Hydrogen (Tri‐
tium), and Sulfur (S-35). Some results for C-14 and Tritium will be briefly presented. There
is an important experiment which shows the contribution of transmutation to the lethal ef‐
fects of C-14. Apelgot and Latarjet [42, 43] incorporated C-14 into the cells of the bacteria
e.coli by culturing in a medium containing 2-14C-thymidine. The samples were stored at
-196 C, The specific activity of the 2-14C thymidine was 166 MBq/milliMol. The experiments
continued for a year. To evaluate the role of the β-radiation, a control non-radioactive bacte‐
ria sample was stored in the presence of 2-14C thymidine in such a way that the radioactivity
per cm3 of this suspension was the same as the study sample. From a comparison of the re‐
sults, the authors concluded that the predominant lethal effect was from transmutation with
an efficiency of 160-times that which would be obtained from the β-radiation. Similar results
have been obtained from studies of C-14 by Anderson and Person [44, 45] who put the haz‐
ard coefficient relative to β−radiation at 10-fold. These authors studied the mutagenic effect
of C-14 and compared transmutation with external X-ray doses. Pluchennik [46, 47] studied
the mutagenic effect of C-14 decay in Chlorella grown in a medium containing a single car‐
bon source with different fractions of C-14. The number of mutants from the C-14 rose rap‐
idly at low fractions and quickly saturated due to killing effects; the data showed that the
mutagenic effect considerably exceeded that due to external radiation. Other research car‐
ried out in the 1960s has largely confirmed this generalisation [2].
The genetic effects of incorporation of C-14 are of concern since the atmospheric nuclear
tests in the 1950s and 1960s greatly increased the C-14 in the atmosphere. The genetic hazard
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to man was first pointed out by Totter et al [48] in 1958 and also by Pauling [49]. A number
of studies were carried out on different systems. These include onion bulbs [50, 51] grown in
an atmosphere of 14CO2 resulting in chromosome aberrations, micronuclei and elongated
cells. Onion bulbs were also studied by Friedkin and Atchison [52] who compared chromo‐
some aberration in the roots between labelled thymidine (incorporated in DNA) and thy‐
mine (not incorporated). The frequency of aberrations was 3.95% for the thymidine but only
0.43% for the thymine, showing that the effect of transmutation was 9-times that of the β
−radiation. A study of the effect of the C-14 position in the thymidine [53] showed quite
clearly that it was transmutation that was the cause of the effects.
Kuzin et al [54, 55] compared the transmutational component of C-14 incorporation with ex‐
ternal γ radiation in the broad bean. The amount of chromosomal aberration in 2 days was
found to be 25-times per rad for the transmutational component. Other studies on drosophi‐
la [56, 57] give results which suggest that the mutagenic efficiency of C-14 is about three
times that of chronic external γ radiation. Valuable reviews of effects from Tritium and Sul‐
phur-35 are presented in [2].
Tritium has been increasing in the biosphere since the nuclear atmospheric testing. The main
form in which it exists is tritiated water (HTO) but the nuclide also is incorporated into car‐
bon compounds e.g. CH3T and this is termed organically bound Tritium. Tritium is also em‐
ployed for radioactively labelling compounds in chemical, medical and biochemical
research. Tritium has a half-life of 12.6 years and radiates low energy β-particles (0-18 keV )
and when incorporated in a molecule it transmutes to Helium with molecular restructuring
and ionisation and realises a recoil energy of 0-3 keV. These events convey a high probabili‐
ty of destruction or inactivation of the parent molecule. If this is a macromolecule, local re‐
structuring may alter the tertiary folding structure and inactivate the entire molecule. Thus
the effects of Tritium are amplified in the ratio of the molecular mass to the Tritium mass,
which may be by orders of magnitude. The question of whether these results show enhance‐
ment of effect relative to externally calculated absorbed dose does not seem to have been ad‐
dressed either for lethality or mutation. Experiments with very low dose exposures of
Tritium to invertebrates have identified significant developmental effects [58]. Tritium is al‐
so of interest as a pseudo-second event nuclide (see below) owing to the fact that the num‐
ber of events associated with unit dose is far greater than the mean event number associated
with background gamma radiation.
4.4. Temporal location: The second event theory
It  is  well  known that  dividing cells  are more sensitive to radiation than quiescent cells.
Once cells are committed to division, they enter the active part of the cell  cycle,  during
which  DNA  repair  takes  place  followed  by  cell  division.  It  is  therefore  clear  that  any
damage or signal which moves cells from quiescence into the repair replication sequence
puts  the  cells  into  a  condition where  a  second damaging event  will  carry  an enhanced
risk of mutation or lethality.  This is  the basis of the Second Event Theory [18,  19].  This
postulates  that  split  doses to the cell  DNA, separated by 10-12 hours,  will  represent  an
enhancement  of  hazard.  The sequence is  vanishingly unlikely for  external  natural  back‐
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ground  irradiation  but  exceedingly  likely  for  a  number  of  specific  internal  sequential
emitters.  These include exposure regimes involving Sr-90/Y-90,  Te-132/I-132 and various
others.  They  include  hot  particles  (since  there  are  continuous  releases  of  tracks  from
these)  and also Tritium which,  due to its  very low decay energy,  produces many more
tracks per unit dose than natural background radiation.
The probabilities of second event processes occurring can be calculated but depend on basic
assumptions. A paper by Cox and Edwards of the UK National Radiological Protection
Board [59] concluded that the cell dose enhancements were finite but low. However it was
pointed out that there were major faults in the cell dimensions employed in this study [60].
Clearly, the enhancement is a function of the location of the Second Event nuclide, the factor
increasing sharply as the critical volume is reduced. For location on the DNA the potential
enhancement becomes enormous. Table 5 shows results for Sr90/Y90. A number of studies
have indeed shown anomalous genetic hazard from Sr-90/Y-90 [7, 18]. However, since
Strontium also binds to DNA it carries enhancement from other mechanisms. An interesting
experiment which suggests that there are 2nd event effects from Sr-90/Y90 was a comparison
of the genetic damage effectiveness of Sr-90 and the singly decaying Sr-89 on yeast suspen‐
sions at the same doses. The results showed that the Sr90 was four-times as genetically dam‐
aging as the Sr89 for the same dose [61]. Further support comes from cell culture
experiments with split doses of X-rays which show an enhancement of effect for split dose
regimes during the repair replication period [18, 62, 63]. In view of the important implica‐
tions this has for medical X-ray and radiology the question should be examined by further
research. Such research might include (a) split dose research on living animals, e.g drosophi‐
la, zebra fish, (b) comparison of sequential decay effects from indentical elements with dif‐
ferent decay sequences e.g. Sr-90/Y-90 vs. Sr-89.
External dose comparison 2
nd Event
enhancement probability [19]
Cox and Edwards (2000)[59]
Cox Edwards and Simmonds (2004)
[6]
1 mGy 30 1.3
0.1 mGy 200 8.6
0.01 mGy 1900 82
0.001 mGy 9400 407
1 atom per g of tissue 5 x 109
Table 5. Second Event Enhancements for Sr-90/Y-90 ( From Busby 1998 [19])
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4.5. Secondary photoelectron effects
The quantity employed in radiation protection, absorbed dose, is defined as D = ΔΕ /ΔΜ. Hith‐
erto, the mass into which the energy has been diluted is that of living tissue; ICRU provide
tables of absorption coefficients for different living tissue, adipose, bone, muscle etc. which
can be employed for calculations involving doses, but generally all these denominator quan‐
tities have the absorption characteristics of water (H2O) (ICRU35 1984). The absorption of
electromagnetic (photon) radiation is due to a number of processes, the main three being
pair-production, Compton scattering and photoelectron production. For elements of atomic
number greater than about 30, and for photon energies of less than about 500 keV, the pho‐
toelectric effect predominates. Even for the low atomic number elements that make up liv‐
ing systems, there is fairly quantitative conversion of incident photon radiation below 200
keV (and induced photon radiation from second order and third order processes) into pho‐
toelectrons. These are fast electrons which are indistinguishable from beta radiation and
have the energy of the incident photon minus their binding energy (which is generally far
less than the incident photon energy and can be ignored). The absorption of photon radia‐
tion by elements is proportional to the fourth or fifth power of the atomic number Z. Thus
the predominant absorber in water is the Oxygen atom Z=8 and it is reasonable to give the
effective atomic number of water as 7.5. Of course, there are elements in tissue with higher
atomic numbers, but interestingly, apart from Iodine (Z=53) few elements with Z>26 (Iron,
Fe).The incorporation of high Z elements into living systems would generally be harmful
since it would increase the radiation dose, and therefore such developments have been lost
though evolutionary selection. Iodine is an exception, but it should be noted that the main
sites for radiation damage in terms of sensitivity are the main sites for Iodine concentration,
the thyroid gland and the blood. It has been suggested that the metabolic and cell repair sta‐
tus controls exercised by the thyroid gland are the reason why Iodine has been incorporated
into living systems and is employed as a kind of radiation-repair control mechanism [17].
A problem in radiation protection arises when high Z elements are incorporated into liv‐
ing tissue, since the enormously greater absorption of photon radiation by such material
will  result  in  enhanced  doses  to  tissues  adjacent  to  the  high  Z  material.  The  problem
was first addressed in 1947 in relation to X-rays of bone [64] and has been studied in the
past in relation to prostheses. More recently, interest has shifted to the use of high Z ma‐
terial to enhance photon radiotherapies for tumour destruction where it has been shown
to  be  effective.  Gold  nanoparticles  have  been  successfully  employed (and patented)  for
radiotherapy enhancement [65].
Despite this knowledge, the enhancement of photon radiation by high Z contaminants has
not been addressed in radiation protection. The situation may have arisen out of the fact that
prosthetic materials are not intrinsically radioactive and contamination from high Z ele‐
ments like Lead (Z=82) are considered under the heading of chemical toxicity. The issue was
raised in 2005 [66, 67]. It was pointed out that there are two circumstances where the Secon‐
dary Photoelectron Effect (SPE) would have significant radiological implications. These are
(a) for high Z elements that bind to DNA and (b) for internal high Z particulates. In the lat‐
ter case, the effect will increase as the particle size is reduced, since for massive high Z con‐
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tamination e.g. prostheses, most of the photoelectrons are wasted inside the bulk material.
The emergence of the photoelectrons into tissue is a function of the mean electron path in
the material, and the absorbed dose in local tissue is a function of the electron range and
thus its energy.
The radiological implications of the idea emerged in considering the anomalous health ef‐
fects of Depleted Uranium weapons and were presented to the CERRIE Committee in 2003
and the UK Ministry of Defence in 2004 although nothing was done. More recently there
have been attempts to quantify the effects for particles through Monte Carlo modelling [68,
69], but these have not generally been very credible treatments or able to cope with the small
volumes of complex media involved, and the results have been far removed from the few
experimental data published [70, 65].
The particular concern is for the element Uranium, since this has been employed since 1991
as a weapon; the Depleted Uranium (DU) penetrators, used from the 1991 Persian Gulf War
onward, produce a fallout comprising sub-micron Uranium Oxide particles which are envi‐
ronmentally mobile and respirable. Uranium has another quality which makes it of interest
in SPE; as the uranyl ion UO2++ it has a very high affinity for DNA phosphate: some 1010 M-1
[30]. This affinity has been known since the 1960s when it was first employed as an electron
microscope stain for imaging chromosomes [31].
The SPE is therefore likely here to cause enhanced photoelectron ionization at the DNA due
to enhanced absorption of natural background radiation (or medical X-rays). A similar proc‐
ess occurs with the Platinum chemotherapeutic agent cisplatin which binds to the DNA and
acts as an antenna for background radiation and radiotherapy beams.
For SPE phantom radioactivity in other elements of high atomic number, the tissue doses
are enhancements of the incident photon dose at the point of the atom or particle being con‐
sidered. Due to the complex interactions these local doses must be determined by experi‐
ment. However, these experiments are straightforward and involve X-irradiation of high Z
element contaminated tissue at different doses. In principle, this development suggests that
the internalization of any high Z particle which is biologically long-lived will cause continu‐
ous irradiation of local tissue cell populations, which would represent a carcinogenic haz‐
ard. This has implications for those employing prosthetic materials and also for the
dispersion of high Z particles (Tungsten, Platinum, Bismuth, Lead) in the environment. It al‐
so suggests that it may be of interest to examine tumours for the presence of high Z particles
at their centre. Table 6 lists a number of potentially hazardous SPE elements.
Finally it should be pointed out that physical modelling through Monte Carlo codes is un‐
likely to establish useful data and certainly should not be employed as an attempt to dismiss
the importance of the proposed mechanism.
Nevertheless, a FLUKA Monte Carlo model of the absorption by nanoparticles of Gold and
Uranium carried out by [71] Elsaesser et al 2007 graphically confirmed the effect. The results
for photoelectron track production following absorption of 100 keV photons is shown in Fig
6 below. Enhancement factor in this calculation for the 10nm Uranium particle relative to
water was approximately 8000.
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Figure 6. Photoelectron tracks emerging from (left to right) 10 nm particles of water (Z=7.5), Gold (Au; Z =79) and
Uranium (U;Z=92) after irradiation with 100keV photons. Monte Carlo (FLUKA code) analysis. Track numbers are in
proportion to the 4th power Z law (tracks are shown as projections on a flat plane). Note that the model uses 1000
incident photons for Au and U but 10,000 for water [71]
Material Z Z4/tissue Source Note
U 92 22642
Weapons particles, nuclear fuel
cycle, atomic and thermonuclear
bomb tests
Binds to DNA; known to cause cancer
in animals and genomic damage at
very low concentrations
Th 90 20736 Incandescent mantlesContrast media Highly insoluble
Bi 83 14999 General contaminant Insoluble
Pb 82 14289 General contaminant Toxic; SH binding
Hg 80 12945 General contaminant Toxic; enzyme binding
Au 79 12310 Prostheses; colloid used forrheumatism
Friction particles may travel in body;
inert and insoluble
Pt 78 11698 Vehicle catalysers, generalcontaminant Inert and insoluble
W 74 9477 Weapons; general particlecontaminant
Associated with child leukemia cluster
Fallon Nevada; known to cause
genomic damage and cancer in
animals.
Ta 73 8975 Capacitors
I 53 2493 Thyroid, blood plasma Radiation sensitivity
Table 6. Biologically significant environmental contaminants and materials exhibiting phantom radioactivity through
the Secondary Photoelectron Enhancement (SPE) of natural background and medical X-rays
4.6. Fat soluble radioactive noble gases
The nuclide Krypton-85 has been released to the biosphere continuously since 1945 and in‐
creasingly from nuclear energy processes. With a half-life of 10.7 y and a β decay of 672 keV
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the concentration in the atmosphere has been building up to the extent that liquid air is now
significantly radioactive. The assessment of harm from Kr-85 has generally been associated
with skin doses from β decays in air. However Krypton (and Radon) are far more soluble in
fats than in water and this water/oil partition driven equilibrium might cause build up of
these nuclides in lymphatic tissue as a result of equilibria in the lung.
5. Conclusions and recommendations.
5.1. Epidemiology: Uranium effects
The current radiation risk position, that of the ICRP and its associated organisations, has
been adequately reviewed by Harrison and Day [72]. With regard to the questions raised in
the present overview, the only useful discussion in this paper, as in the CERRIE majority re‐
port [6], is the belief that the application of external risk models to internal exposures is sup‐
ported by epidemiological studies of Thorotrast and Radium. It is therefore worth briefly
looking more closely at these.
5.2. Radium and thorotrast studies: Re-examining the data
The increasing pressure brought to bear on the ICRP risk model focuses intensely on the ar‐
guments about internal and external radiation exposure rehearsed in the previous section.
The ICRP and the radiation protection agencies have to concede much of the science, but fall
back on the epidemiology. The problem is, very little human epidemiologic research has
been done on internal radionuclide exposures. There are, however, two sets of studies which
are said to broadly support the arguments that the current risk model is correct. These are
the studies of individuals medically treated with Radium and Thorotrast. The studies origi‐
nally were carried out because of doubt over the use of the external based risk model to deal
with internal radionuclide exposures at a time when internal exposures from alpha emitters
like plutonium were increasing in proportion to the development of the A-Bombs and H-
Bombs. All of these studies were of roughly the same type. A group of individuals was for‐
malised and then records were traced, or the individuals themselves were traced to see what
the number of cancers were. The end point was always cancer, since the project was to see if
the ICRP cancer risk model was accurate for these internal exposures. The medical and other
(e.g. laboratory) exposures to Radium had been largely before 1960; e.g radium clock dial
painters, and there were many of these who had survived from the period when they were
employed. In addition there were individuals who had been exposed to Ra-224 as a treat‐
ment for various illnesses. There had been a fashion to treat syphilis, hypertension, gout, in‐
fectious polyarthritis, “muscular rheumatism”, anaemia, epilepsy and multiple sclerosis [29]
with radium. Then there were many individuals who had been injected with the substance
Thorotrast, an X-ray contrast medium based on the nuclide Th-232, the daughter of which is
Ra-228. So these are all internal radium exposures. What was reported in studies was that
the cancer yields, mainly of liver cancer, bone cancer, and leukaemia could be roughly relat‐
ed to the exposures and that the yield was not too far away from the yield predicted by the
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ICRP external type of risk model, i.e. the A-Bomb survivors. These studies are the last re‐
maining defence that the current risk agencies can mobilise. There are a number of fatal
problems with all the radium studies:
• The study groups were assembled long after the exposures and so not all those who had
been exposed were in the study group: only the survivors. Many were dead. This biased
the samples.
• A number of published studies give sufficient data to show that there was a high rate of
death in the early period before the groups were assembled.
• The doses were not isotropic; for Thorotrast, the material was stored in depots in parts of
the body where cells were quite resistant to radiation.
In addition, the doses were very large, so these studies were not of low dose chronic expo‐
sure but were in fact high dose internal chronic exposure.
Some of these problems were raised in 1970 in relation to the pioneering work by Rob‐
ley Evans. Evans was a physicist  and was concerned with the question of physical dos‐
imetry of  small  quantities of  internal  emitters.  Writing in the British Journal  of  Cancer  in
1970, JF Loutit [29] took issue with the methodology of the Radium studies and pointed
out that the massive bone marrow damage resulting from Radium exposure (which had
been reported by many authors before Evans) would result in a very large excess death
rate  from a  range of  diseases.  Loutit  wrote  that  the  limiting hazard from internally  re‐
tained radium acquired occupationally being bone cancer needed to be reconsidered. He
pointed out  that  evidence already existed in  the  1930s  from the  work of  Martland that
those with substantial body burdens of radium had considerable life shortening and that
the associated pathology had not been clarified. Loutit re-examined the radium dial case
reports and found that internal radium had a profound effect on the bone marrow, best
described  as  leukopenic  anemia.  This  identifies  one  source  of  increased  risk  from  non
cancer illness and death which would have removed individuals from Radium and Thor‐
otrast  study  groups.  Indeed,  the  problem  with  all  these  studies  is  that  they  exclude
about half of the exposed population who may have been lost to the researchers but are
very likely to have died of cancer or a range of non cancer illnesses. In the better report‐
ed studies, where more data is made available, it is possible to see that this is indeed the
case.  An example is  Wick et  al.  (1983)  who examined cancer  in  Ra-224 patients.  I  have
reduced  the  data  from  a  diagram  in  this  paper  to  produce  the  graph  in  Fig  7  which
shows the  percentage  dead in  the  age  group at  exposure  by  the  period between expo‐
sure  and death.  It  is  clear  from the  trend that  for  all  the  groups,  the  most  deaths  will
have occurred in the first five years in individuals that were not in the study group.
This Ra-224 study by Wick et al.  [73] is of the exposure group of German patients who
were treated between 1948 and 1975 with Ra-224 for ankylosing spondylitis.  There were
1501 total patients, among them 69 were missing and 433 were dead. What did they die
of? We don’t  hear.  But  3  of  them developed bone cancer,  5  developed leukemia,  and 6
bone  marrow  failure  (cf  Loutit  above).  This  tiny  cancer  yield  may  approximate  to  the
range predicted by the ICRP model (assuming that the dose could be accurately descri‐
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bed) but what about the missing people? What about the 433 who died? If they died of
conditions  caused by the  stress  on their  immune system (bone marrow failures  and si‐
lent  bone marrow problems) then the cancer yield is  not a proper representation of  the
effects  of  the radium exposures  on this  group.  And the cancer  yield to  produce an ap‐
proximation to the ICRP risk predictions for leukemia is lower than in the control group.
Addition of  a  handful  of  cases  from the missing individuals  or  a  handful  of  pre-leuke‐
mic immune-compromised individuals from the 633 dead would have a profound effect
on the outcome of the study.
Radium 224 Patients; % of age group at Exposure vs. Time at 
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Figure 7. Percentage of each age group at exposure plotted against years to death from exposures in the Ra-224
study of Wick et al 1983. [73]
A similar picture is found in the thorotrast studies, where it is possible to see enough data.
For example, in the paper by Mori et al 1983, 282 Japanese war wounded ex-servicemen
thorotrast cases are followed up [74]. There were deaths from liver cancer, cirrhosis of the
liver and also blood diseases. But in 170 deaths in the group, 42% were from cancer and 37%
from other causes. There was no dose response for the cancers and the cancer yield was
about 20-times greater than expected from ICRP. But the most interesting aspect is that from
analysis of this group, the death rate was very high and the age at death very low compared
with all Japanese populations. This is missed in the report since the method employed was
to choose sick pathology controls from a hospital pathology records sample. I have com‐
pared their age specific death rates with all-Japan. Plots of the survival curves in the females
in this group show that 100% were dead by age 75 compared with 65% for the equivalent
all-Japan population. Results are given in Fig 8.
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Of course, about 40% of these study group women died of cancer: the effects of the thoro‐
trast. But note that the others died from something else; they didn’t live to a ripe old age nor
did they live as long as the all Japan population. This is clear from the survival curves in
Figure 8 which show almost a 20 years age effect in the women. For men, the shift was about
9 years (my unpublished results, not shown).
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Figure 8. Survival curves for female thorotrast patients studied by Mori et al 1983 compared with all Japan. Data re‐
duced from tables in Mori et al 1983 [74] and Japanese government publications.
The conclusions of this brief account of the re-examinations of the radium and thorotrast
studies show that they cannot be used as indicators for low dose chronic risk to internal ra‐
dionuclides. Apart from the fact that the doses were (like the A-Bomb doses) very large, the
main fatal flaw was and is that confounding causes of death make the cancer yield conclu‐
sions unsafe. Loutit 1970 makes the point that the damage to the bone marrow would be
likely to occur in the case of the weapons-fallout component Strotium-90, and he urged the
research community to concentrate on examining risk from that nuclide, an exhortation
which the research community entirely failed to take notice of. Loutit was a Medical Re‐
search Council MRC (Harwell) director.
5.3. Uranium
The anomalous health effects of exposure to Uranium, especially in the form of particulates,
have been increasingly clear in the last 10 years. The radiobiological evidence is reviewed in
ECRR2009 [75] and there is insufficient space here to do more than note that the current risk
external radiation based model cannot begin to explain or predict what is found empirically.
Despite the massive evidence including studies by nuclear industry and military scientists,
the agencies ICRP, UNSCEAR, BEIR et al persist in their assertions that the observed effects
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cannot be due to Uranium. Most recently there have been studies of French Uranium work‐
ers showing leukemia and lymphoma excess, lung cancer excess and heart disease at doses
which are too low by some 2000-times to explain them on the basis of current risk models
[76, 77, 78]. There is an urgent need to carry out research into this issue. The effects of photo‐
electron amplification can easily be examined by studies involving varying external X-ray
doses at different concentrations of Uranium particulates and molecular Uranyl ion in cell
culture and animal studies. There is no routine measurement of Uranium in the vicinity of
nuclear sites. This should also be remedied.
5.4. other epidemiological evidence
5.4.1. Childhood cancer near nuclear installations
There have been reports in peer reviewed journals of increased risk of childhood leukemia
and non Hodgkin lymphoma near many nuclear sites in Europe. A list and discussion may
be found in ECRR2010. Child leukemia excesses are found near nearly all the sites that have
been examined [5]. e.g the reprocessing sites at Sellafield [37] Dounreay UK [79] and La Ha‐
gue (France) [80] near the Atomic Weapons Establishment Aldermaston (UK) [81], the
Atomic Energy Research Establishment Harwell (UK) [82], near Hinkley Point nuclear pow‐
er station (UK) [83] and recently near all the combined nuclear sites in Germany (KiKK
study) [84] and near all the combined nuclear sites in France [85], GB, and Switzerland.
The radiation risk community [86, 87] basing calculations on the ICRP risk model have
worked out the dose ranges and say they cannot be more than a few microSieverts, well be‐
low Natural Background. The ICRP risk model predicts an excess risk of 0.05 cancers per
Sievert. 100 microSieverts is 1/10,000 th (10-4 of a Sievert). An Excess Absolute Risk of 0.05/Sv
is Excess Relative Risk (ERR) of 5E-8 per μSv. This, divided by the spontaneous risk of 3E-4
for 0-4 y old children, is 1E-3 per 6 microSv. But there are twice as many child leukemias as
are expected: a doubling of risk: the ERR observed in the KiKK study was ~ERR=1. So ICRP
predicts a 1000-fold lower risk than found in the KiKK study.)
The ICRP does not give a risk factor for childhood leukaemia but to define a difference be‐
tween external and internal exposure we can employ the Excess Relative Risk based on the
obstetric X-ray studies analysed by Wakeford and Little [88]. This gives an Excess Relative
Risk of 50/Sv and based on the 40/Sv Obstetric X-rays results of Alice Stewart.
Stewart found a 40% excess risk after an X-ray dose of 10 mSv [88]. That would suggest a 4%
increase after 1 mSv, 0.4% after 100 μSv. But we are seeing a 100% increase at this level. The
error is now 100/0.4 = 250-fold.
5.4.2. Infant leukemia after Chernobyl
Five different groups [89-93] reported a statistically significant increase in infant leukemia in
5 different countries of Europe in those children who were in the womb at the time of the
Chernobyl Caesium-137 fallout as measured by whole body monitoring. The effect was also
reported from the USA [94]. Thus the Chernobyl exposure is the only explanation for the in‐
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crease. This occurred and was reported from Greece, Germany, Scotland, Wales, Belarus,
USA and the error this shows in the ICRP model was the subject of two peer reviewed pa‐
pers in 2000 [92] and 2009 [25]. Using the Alice Stewart relation between dose and leukemia
above, the error is about 400-fold (depending on the country) [25]. Using the ICRP model it
is upwards of 1000-fold. This analysis is most relevant since it unequivocally supports the
causal relation revealed by the nuclear site child leukemias yet in this case fission product
internal radiation can be the only cause.
5.4.3. Cancer following Chernobyl in Northern Sweden
The study by Martin Tondel found a 11% increase in cancer for every 100 kBq/sq metre of
Cs-137 from Chernobyl [95]. It is possible to calculate that 100 kBq/m2 Cs-137 including a
further 100kBq/ m2 of Cs-134 if reduced exponentially due to rain washout to rivers and
lakes with half life of 6 months would give a committed effective dose of about 1 mSv. The
ICRP model [96] predicts an Excess Relative Risk of 0.45 per Sv, so the ICRP expected excess
relative risk, including a Dose Rate Reduction Factor of 2 (as used by ICRP) is 0.0225%. The
error in ICRP model defined by Tondel’s result is thus 490-fold.
5.4.4. Human sex ratio at birth perturbed by low doses of internal fission-product ionising radiation
Studies by Hagen Scherb and Kristina Voigt [97] show clear and highly statistically signifi‐
cant alterations in the human sex ratio at birth (the number of boys born to girls) after (a)
atmospheric bomb testing, (b) Chernobyl and (c) near nuclear facilities. Effects are shown to
be local, European (several countries were studied) and global, supporting earlier evidence
of increases in infant mortality during the period of atmospheric weapons testing [98, 99].
Sex ratio has been accepted as a measure of genetic damage with the preferential killing of
one or other sex depending on the type of exposure (mothers or fathers). According to
Scherb and Voigt, millions of babies were killed in utero by these effects [100]. A recent re-
analysis of the sex ratio effect in Hiroshima reveals the effect in those populations also [101],
evidence which was overlooked by the USA researchers through poor epidemiology and
questionable decisions. This evidence objectively confirms the serious genotoxic effect of in‐
ternal ionising radiation on germ cells and the exquisite sensitivity of humans and other liv‐
ing creatures to releases from Uranium fission. The ICRP does not consider such effects nor
are they included in any assessment of harm.
5.4.5. Cancer and genotoxic effects in Iraq following DU exposure
A series of studies of the population of Fallujah Iraq shown [102- 104] to have been exposed
to Uranium following the 2003-2004 battles have revealed extremely high rates of congenital
malformations at birth and cancer and leukemia/lymphoma in adults. The studies also draw
attention to significant sex ratio effects at birth beginning after 2004. These results, and the
increases in genotoxic effects in the offspring of Gulf veterans support and are supported by
the other sets of observations reviewed above which show that inhaled Uranium nanoparti‐
cles represent a very serious hazard which is entirely overlooked by ICRP.
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5.4.6. Chernobyl effects as reported in the Russian peer-reviewed literature
The effects  of  the Chernobyl  accident exposures have been reported in the Russian lan‐
guage peer review literature since 1996. These results have been reviewed by Busby and
Yablokov 2006 [105] Yablokov et al 2010 [106] and Busby et al 2011 [107] but have been
largely  ignored  by  ICRP.  They  constitute  a  very  large  body  of  peer  reviewed  work
which  show  that  the  effects  of  the  Chernobyl  accident  exposures  are  massive  and  ex‐
tremely serious [108]. They range from cancer and leukemia to heart disease especially in
children together with a range of illnesses which can be best described by the term pre‐
mature ageing [108]. They include congenital transgenerational diseases and are reported
in  animals  and plants  which  cannot  be  affected by  the  kind of  psychological  processes
(radiophobia) which have been employed by the radiation risk establishment to account
for the early reports coming out of the affected territories. In addition, there are objective
measurements  of  serious  biological  harm to  humans and other  living creatures  affected
by the  exposures.  The  germline  mutations  found by  minisatellite  tests  [109]  in  humans
were  also  associated with  real  morphological  effects  and fitness  loss  in  birds  [110]  and
were  shown to  have caused significant  sex  ratio  changes  in  the  birds  and also  popula‐
tion loss [111] which is in agreement with the findings of Scherb and Voigt and the in‐
fant  mortality  findings  [98,  99].  The  implications  for  the  understanding  of  the  historic
effects of the nuclear project on human health are alarming.
5.5. Summary and conclusions
The current radiation risk model is insecure for internal radionuclide effects. Massive evi‐
dence exists from epidemiology and also published studies of the effects of internal radionu‐
clide exposures that the effects of location, chemical binding or affinity, temporal decay
patterns and transmutation of internal radionuclides can have much greater genetic or lethal
effects on cells than are predicted by the absorbed dose model. These data have been pub‐
lished since the 1950s but ignored for the purpose of radioprotection. Many critical research
issues should have been pursued but have not been. It is recommended that those issues
and research studies highlighted in this contribution are seen as a priority.
Appendix
Calculating the probability of a track interception with DNA as a function of distance of
the point source
The model is given in Fig 9 and Fig 10. It  locates the source at the centre of a sphere S
radius r distance d from the DNA which is modelled as a cylinder of length 2R. We put
r<D. Any decay which intercepts an infinitesimal strip of area A on the DNA cross sec‐
tion  can  be  mapped onto  a  small  area  B  on  the  surface  of  the  sphere  S.  The  required
probability  assumes that  the decay can be in  any direction.  It  is  thus equal  to  the area
B / total area of the sphere.
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Figure 9. Model
From Fig 2, tan θ = R/d; θ = arctan (R/d)
Length of arc A = 2rθ = 2arctan (R/d)
d’ = d/cos θ; θ = arctan (R/d’) = arctan ((Rcos α)/d)
Area B (Fig 1) = 2rθ. rdα = 2r2 arctan((Rcos α)/d)
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Figure 10. Model from top and side
Area B (Fig 1) = 2rθ. rdα = 2r2 arctan((Rcos α)d)
Whole area of segment =
4r 2∫0π/2arctan((Rcosα) / d )dα
And the required probability is this divided by the surface area of the sphere 4πr2
P (DNA) =  1π ∫0π/2arctan((Rcosα) / d )dα
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